Disease | small cell carcinoma |
Comorbidity | C0010481|cushing syndrome |
Sentences | 1 |
PubMedID- 26508941 | Retrospective studies have shown that median survival of sclc patients with cushing syndrome ranges from 3.5 to 5.5 months, suggesting that the presence of eas is a poor prognostic factor12. |
Page: 1